Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use With Omalizumab From the Real-World PROSPERO Study

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.303
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Omalizumab Reduced Inhaled Corticosteroid Use and Exacerbations in Childhood Allergic Asthma

Evidence-Based Medicine
Medicine
2002English

Real-World Effectiveness of Mepolizumab in Patients With Severe Asthma: An Examination of Exacerbations and Costs

Journal of Asthma and Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2020English

Viruses and Asthma Exacerbations

Thorax
PulmonaryRespiratory Medicine
1998English

Viruses and Asthma Exacerbations

Breathe
PulmonaryRespiratory Medicine
2006English

Expression Profiling of Genes Related to Asthma Exacerbations

Clinical and Experimental Allergy
AllergyImmunology
2009English

Omalizumab Treatment in Brittle Asthma

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2014English

Biomarkers and Outcomes in Omalizumab-Treated Patients With Allergic Asthma: A Real-World Study in a Large Allergy Practice in the United States (US)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Serum Vitamin D Levels and Severe Asthma Exacerbations in the Childhood Asthma Management Program Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2010English

Greater Treatment Benefit With Omalizumab in Children With Increased Asthma Severity: Exploratory Analyses From the Inner-City Anti-IgE Therapy for Asthma (ICATA) Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy